Skip to content

From target gene to lead compound

leadXpro specializes in structure-based drug discovery for membrane proteins.

Achievements as of December 2022:

  • Total number of targets solved: 25, (23 ion channels, 22 GPCRs, 13 transporters, 3 enzymes).
  • Novel targets enabled: 7
  • Total number of proteins: 61

We have an integrated platform for membrane protein biochemistry, biophysics and structural biology, including X-ray crystallography and cryo-EM.

LXP_Technology_

Our technology partners

Biozentrum_Basel_Logo_2011550px
cdd-vault_blue-center-850x225
creoptix
interax
psi
structura
uni-basel
uni-zuerich
LXP_Technology_Contact_portrait-s

Contact

leadXpro AG
PARK InnovAARE
CH-5234 Villigen
Switzerland